Fundraising FoxPappas Capital
Venture capitalResearch Triangle Park · Seed–Late Stage · 15 people tracked
Also known as A.M. Pappas & Associates, LLC · PAPPAS CAPITAL, LLC
Not to be confused with Pappas Capital (Venture capital · Durham, US)
Find your way into Pappas Capital
1,858 people in our graph share verified history with the Pappas Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Pappas Capital focuses on the life sciences, investing in and building companies that develop next-generation products and technologies addressing the full range of human disease. Over more than three decades the firm has backed 100+ companies across the United States, Canada, and Asia, whose products have reached the market to treat conditions such as melanoma, ovarian cancer, and hemophilia. The firm brings hands-on operating and investment expertise, and also runs specialized fund management vehicles including the Chiesi Ventures Fund, Asia Innovation Ventures, AgTech initiatives, and translational medicine programs. It works with both entrepreneurs seeking capital and partners looking to invest.
Source: firm website, verified Sep 26, 2026.
Team · 15 people
from curated & public directories
Founder mafia
2 people who came through Pappas Capital went on to found or lead other companies.
What they invest in
from 15 of 18 portfolio companiesBiotech ×10Healthtech ×8Medical Devices ×3Climate Tech ×2AI & Machine Learning ×1Cleantech ×1Cloud Computing ×1Consumer ×1
HQs:United States×9Germany×1Singapore×1Vietnam×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 32021 · 12020 · 32018 · 32017 · 214 dated
4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.
BiotechHealthtechEmeryville, US
David Kirn(Executive Officer, Director)inDavid Schaffer(Director)inTheresa Janke(Executive Officer)in
BoardSharon Tetlow(Director)Margi McLoughlin(Director)
Co-investorsAmzak HealthBerkeley CatalystBOLD LongevityChiesi VenturesPappas CapitalPfizer Venture Investments+6 more
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.
BiotechHealthtechMedical DevicesBoston, US
Todd Foley(Co-founder and Chairman)inPatrick Baeuerle(Co-founder & Advisor)inShulamit Ron-Bigger(Executive Officer)inKyle D. Kuvalanka(Chief Financial Officer)inAkos Czibere(Chief Medical Officer)inPaul L. Feldman(Chief Scientific Officer)in
Co-investorsAndreessen HorowitzEcoR1 CapitalMPM BioImpactMRL Ventures FundPappas CapitalRA Capital+5 more
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtechSan Carlos, US
Anthony P. Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Anthony FordinHenry Skinner(Director)Liam Ratcliffe(Director)in
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture Partners+2 more
Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.
BiotechHealthtechMedical DevicesSandy, US
Ciara Kennedy, Ph.D.(Executive Officer, Director)Brian Dorsey(Executive Officer)Michael Grey(Director)Mark Chin(Director)Susan Dube(Executive Officer)
BoardEdward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)NEA Secondary
Developing a new class of antifungal medicine to overcome limitations of current therapies.
Co-investorsBioBritGolden SeedsKeiretsu ForumPappas CapitalSofinnova Ventures3x5 Partners+4 more
Biotechnology company developing the LOCOcyte cell-therapy platform for local dosing of immunotherapeutics.
Co-investorsLongitude CapitalPerceptive Xontogeny VentureRock Springs Capital
Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.
Climate TechEnterprise SoftwarePropTechGermany, DE
Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in
Co-investorsFoundamentalAbingworthAisling CapitalAmzak HealthEurazeoLakestar+4 more
Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.
ConsumerMedia & EntertainmentSports Tech
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworthAmzak Health+2 more
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsHatteras Venture PartnersIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalSV Health Investors+2 more
HealthtechPlymouth, US
Thomas Westling(Executive Officer, Director)inMartha Shadan(Executive Officer, Director)Randy Nuernberg(Executive Officer)Craig Van Kampen(Executive Officer)
BoardFouad Azzam(Director)inScott Weiner(Director)in
Co-investorsNew Enterprise Associates (NEA)Pappas CapitalLSP (Life Sciences Partners)
Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration.
BiotechCloud ComputingHealthtech
Sam Sihvonen(Founder)in
Co-investorsLifeline VenturesWave Ventures
Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels.
BiotechHealthtech
Phil Vickers(CEO / Leadership)inMichael Boretti(Leadership)inBrandon Turunen(Leadership)inSergio Santillana(Leadership)Enda Moran(Leadership)inKelly Honohan(Leadership)in
Co-investorsAstellas Venture Management LLCLongwood Fund
Us2.ai provides FDA-cleared AI software that automatically analyzes echocardiograms and generates structured clinical reports in real time.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsEast Post Road VenturesFJ LabsPartech VenturesPeak XV Partners
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
BiotechSan Diego, US
David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in
Co-investorsChiesi VenturesDecheng CapitalPappas CapitalSofinnova VenturesVedanta CapitalArix Bioscience+2 more
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalSanofi VenturesAlexandriaGenesys Capital+4 more
VFlowTech develops PowerCube vanadium flow battery energy storage systems for commercial, industrial, grid and distributed generation applications in the renewable energy market.
CleantechClimate TechEnergyHardwareSingapore, SG
Avishek Kumar(CEO)inArjun Bhattarai(CTO)in
Co-investorsEntrepreneur FirstUntroD CapitalWavemaker PartnersAntares Ventures Pte. Ltd.Granite AsiaMOL PLUS+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 3
2 IPOs · 1 acquisitions4D Molecular TherapeuticsNASDAQ: FDMTAktis OncologyNASDAQ: AKTSVeraloxacq. by Cadrenal Therapeutics
Portfolio news
latest coverage across their companiesVFlowTech · finsmes.com · May 14, 2025
Solu · finsmes.com · Apr 9, 2025
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2015
Disclosed stake · filed Mar 2014
Disclosed stake · filed Feb 2014
Disclosed stake · filed Nov 2012
Disclosed stake · filed Jul 2011
Disclosed stake · filed May 2011
Disclosed stake · filed Aug 2010
Disclosed stake · filed Mar 2006
Disclosed stake · filed Dec 2005
14 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Pappas Capital made?
- Pappas Capital has 18 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
- What stage does Pappas Capital invest at?
- Pappas Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Pappas Capital's typical check size?
- Pappas Capital typically writes checks of $100K – $6M.
- What sectors does Pappas Capital focus on?
- Pappas Capital focuses on AgTech, Biotech, Healthtech, Medical Devices.
- Where is Pappas Capital located?
- Pappas Capital is headquartered in Research Triangle Park, US.
Images
Co-investors · 6
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Avoro Capital Advisors is an investment firm focused on healthcare and life sciences, pursuing scientific breakthroughs that address unmet medical needs.
Amplitude Ventures is a Canadian venture capital firm that creates, builds, and grows precision medicine companies, investing in human health from ideation through patient care.
Firms observed investing alongside Pappas Capital, from public investor directories. Shared companies are the overlap with Pappas Capital's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.